06/09/2025
4:35 PM | DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:35 PM | Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:36 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:34 PM | Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:34 PM | Honore Tage (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
05/21/2025
8:23 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:06 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
3:31 PM | Vanda Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2025
3:33 PM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for VNDA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/17/2025
8:15 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
4:53 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:44 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:45 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:30 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:13 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:38 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:04 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
7:21 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:43 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
3:46 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
12:40 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
7:22 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:45 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:07 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
7:00 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
4:00 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:10 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:47 AM | Vanda Pharmaceuticals (Filer)
| Form 8-A12B/A | |
08/08/2024
6:29 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:05 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
4:21 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Elon’s NEXT Big IPO? (Ad) Cancel your internet TODAY!?
Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up.
It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry.
But you may only have this chance if you act before December 31st, 2025. One that experts predict could be worth over $3.2 TRILLION globally by 2030. |
07/29/2024
4:24 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:38 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
